When: Weekly close >$260 with MACD histogram no longer expanding negative AND RSI >55

Then: Deploy 0.25x additional

When: Pullback to $220–$228 zone without deterioration in guidance, debt reduction, or dividend coverage

Then: Deploy final 0.35x

When: Close <$245 on above-average volume

Then: Suspend staging plan, reassess thesis within 5 sessions

REDUCE — trim any existing overweight exposure on any rally back toward the 50-SMA at $254; wait for a confirmed basing pattern with MACD histogram turning back toward zero and RSI establishing support above 40; only then consider initiating new exposure at the lower Bollinger Band or on a successful retest of the 200-SMA from above. Explicit invalidation: if price closes below $245 on above-average volume, exit entirely and reassess the long-term thesis.

• Forward P/E of 15.4x looks reasonable in isolation but TTM P/E is 71x — the market is telling us GAAP earnings are weak right now
• MACD histogram is at minus 1.50 and expanding — accelerating downside momentum, not a rounding error
• RSI at 44.6 with room to fall to 30 means genuine downside space before any oversold bounce signal triggers
• 200-day moving average at $226 has not been tested under current conditions of distribution volume, MACD rollover, and $10.9 billion Apogee acquisition in early integration
• If 200-SMA breaks, next support zone is the 52-week low at $190.75 — a 23% drawdown from current levels, not the proposed 9% stop
• Q2 2026 quarterly free cash flow was $3.11 billion against dividends paid of $3.07 billion — a 1.01x coverage ratio with essentially zero margin for any operational hiccup
• Skyrizi represents roughly a third of guided 2026 revenue — single point of failure, not diversification
• Rising bond yields compress present value of future dividend streams and compete for income-oriented capital — 2.78% yield becomes less attractive as 10-year Treasury climbs
• Polymarket pricing 93% probability of no Fed cuts in 2026 means the yield environment stays elevated, pressuring ABBV's multiple
• Aggressive analyst's thesis requires multiple simultaneous tailwinds: earnings normalization, Skyrizi/Rinvoq continued growth, smooth Apogee integration, contained bond yields, 200-SMA hold, and defensively supportive macro
• Conservative modification: initiate no more than 0.25x of intended exposure at current levels (not 0.5x), tighten stop to $232 (not $226), defer second tranche to confirmed weekly close above $260 with MACD histogram turning positive
• Conservative stop-out worst case limits downside to roughly 1% of portfolio

→ vs aggressive: Forward P/E argument ignores that TTM P/E is 71x — the market is signaling weak GAAP earnings, not a benign valuation; earnings normalization that hasn't fully shown up is hope, not foundation

→ vs aggressive: MACD dismissal is 'technically accurate and practically useless' — MACD histogram at minus 1.50 and expanding is confirming a trend shift; ignoring deterioration until it reaches an arbitrary threshold means only acting after damage is done

→ vs aggressive: 200-SMA at $226 called 'reliable structural support' is an untested assumption — it held during a calm grinding uptrend, not under current distribution volume and MACD rollover conditions; stops at structural levels fail fast and violently

→ vs aggressive: Rising bond yields argument is inverted — they compress present value of future dividend streams and compete for income capital, not support it; higher-for-longer regime causes multiple compression, not multiple expansion

→ vs aggressive: FCF coverage concern dismissed too readily — 1.01x coverage leaves zero margin for Apogee integration hiccups or Skyrizi/Rinvoq growth disappointment; a company burning through FCF to maintain its dividend is structurally fragile, not defensive

→ vs aggressive: Concentration in Skyrizi at roughly a third of guided 2026 revenue is a single point of failure, not the 'good kind of concentration'; label expansion faces competition from Rinvoq, Dupixent, and emerging IL-23/IL-17 candidates

→ vs aggressive: Staged position-building assumes market cooperates with the staging sequence — if stock chops sideways and second tranche triggers at $260 instead of $220-$228, the trader adds at a worse price than initial entry

→ vs neutral: HOLD still not cautious enough — in a stock with distribution volume, deteriorating MACD, and razor-thin FCF coverage, sitting and waiting is itself a risk; the appropriate conservative position is REDUCE

Proceed with BUY at 248.50, modified: initiate at 0.5x exposure, maintain stop at 226, add 245 breakdown hard exit trigger, tighten second tranche to require MACD histogram improvement, cap final position at 1.1x normal weight, add quarterly FCF coverage monitoring trigger.

• Forward P/E at 15.4 with revenue growth over 10 percent and PEG of 0.36
• Q2 free cash flow of 3.11 billion against dividends of 3.07 billion is 1.01x coverage ratio
• MACD histogram at negative 1.50 and expanding
• RSI dropped from 68 to 44 in three weeks
• 2.78 percent yield
• 200-SMA at 226
• Lower Bollinger Band at 245
• 6 percent pullback in stock up 24 percent over past year
• 40 percent operating margins
• 17 billion in trailing FCF
• 5 to 6 percent portfolio allocation, capped at 1.1x normal weight vs 1.25x
• 5 percent underwater for 30 days time stop
• 260 level for second tranche trigger with RSI above 55

→ vs aggressive: MACD dismissal is technically correct but functionally useless; histogram at negative 1.50 and expanding signals accelerating downside momentum, not a rounding error

→ vs aggressive: RSI drop from 68 to 44 contradicts 'orderly selling' characterization; deteriorating momentum contradicts structural thesis

→ vs aggressive: Macro bond yield argument is inverted; rising yields compete for income capital and compress multiples, creating headwind not tailwind for ABBV

→ vs aggressive: FCF coverage at 1.01x is structural fragility requiring acknowledgment; cannot dismiss as footnote when dividend is core holding rationale

→ vs conservative: REDUCE call is too aggressive; stock with mid-teens forward P/E, double-digit revenue growth, 40 percent operating margins does not warrant active trimming in defensive macro

→ vs conservative: Tighter stop at 232 sits above 200-SMA at 226 and below lower Bollinger Band at 245, creating whipsaw risk from normal volatility

→ vs conservative: Staging plan framing as 'assuming market cooperates' is straw man; conditional triggers accommodate multiple paths